Skip to main content
Premium Trial:

Request an Annual Quote

AusDiagnostics Gets CE Mark for Multiplex Coronavirus, Flu, RSV Assay

NEW YORK — AusDiagnostics said on Monday that it has received CE marking for its multiplex PCR assay for SARS-CoV2, influenza, and respiratory syncytial virus (RSV).

The firm also said that the panel has been included in the Australian Register of Therapeutic Goods.

The test includes two targets for SARS-CoV-2: one in ORF 1a and one in ORF 8, according to the Mascot, Australia-based company. It achieved 100 percent sensitivity and 100 percent specificity in a study of 210 samples that included 44 from COVID-19 patients. Thirteen of the samples were from patients with either influenza or RSV.

The assay is based on AusDiagnostics' multiplexed-tandem PCR technology, which enables the detection of low concentrations of multiple pathogens in samples with high concentrations of other pathogens.

Versions of the panel are available for both 24-sample and 96-sample instruments manufactured by the company are now available, AusDiagnostics Managing Director Keith Stanley said in a statement.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.